Review



mouse anti human phosphor enos  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Santa Cruz Biotechnology mouse anti human phosphor enos
    The molecular formula of Crocetin (A). Relative viability measured by WST-1 in HUVECs exposed to various concentrations of Crocetin over a period of 72 h (B) (n=12). Measuring HUVECs viability in the combined regime of Crocetin, Wortmannin (a PI3K inhibitor) and NMA (an <t>eNOS</t> inhibitor) (C). Data are expressed as mean ± SD (n=12). *p<0.05, **p<0.01, ***p<0.001 using one-way ANOVA with Tukey post-hoc test.
    Mouse Anti Human Phosphor Enos, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 47 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+phosphor+enos/pmc06868919-61-35-42?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 47 article reviews
    mouse anti human phosphor enos - by Bioz Stars, 2026-08
    93/100 stars

    Images

    1) Product Images from "Crocetin promotes angiogenesis in human endothelial cells through PI3K-Akt-eNOS signaling pathway"

    Article Title: Crocetin promotes angiogenesis in human endothelial cells through PI3K-Akt-eNOS signaling pathway

    Journal: EXCLI Journal

    doi: 10.17179/excli2019-1175

    The molecular formula of Crocetin (A). Relative viability measured by WST-1 in HUVECs exposed to various concentrations of Crocetin over a period of 72 h (B) (n=12). Measuring HUVECs viability in the combined regime of Crocetin, Wortmannin (a PI3K inhibitor) and NMA (an eNOS inhibitor) (C). Data are expressed as mean ± SD (n=12). *p<0.05, **p<0.01, ***p<0.001 using one-way ANOVA with Tukey post-hoc test.
    Figure Legend Snippet: The molecular formula of Crocetin (A). Relative viability measured by WST-1 in HUVECs exposed to various concentrations of Crocetin over a period of 72 h (B) (n=12). Measuring HUVECs viability in the combined regime of Crocetin, Wortmannin (a PI3K inhibitor) and NMA (an eNOS inhibitor) (C). Data are expressed as mean ± SD (n=12). *p<0.05, **p<0.01, ***p<0.001 using one-way ANOVA with Tukey post-hoc test.

    Techniques Used:

    Gelatin zymogram showing MMP-9 and MMP-2 activities in HUVECs treated with Crocetin (A) (n=3). RT-PCR analysis of VEGF expression (B) (n=3). Western blot analysis of p-Akt/Akt ratio (C). Western blotting revealed the non-significant increase of p-Akt/Akt ratio during the 45 min-incubation of HUVECs with 50 µM Crocetin and these effects were diminished from time points 60 to 120 min. (n=3). Measuring the p-Akt/Akt and p-eNOS/eNOS ratios by ELISA (D, E, and F) (n=12) by using One-way ANOVA and Tukey's Post Hoc. * p <0.05; ** p <0.01; *** p <0.001.
    Figure Legend Snippet: Gelatin zymogram showing MMP-9 and MMP-2 activities in HUVECs treated with Crocetin (A) (n=3). RT-PCR analysis of VEGF expression (B) (n=3). Western blot analysis of p-Akt/Akt ratio (C). Western blotting revealed the non-significant increase of p-Akt/Akt ratio during the 45 min-incubation of HUVECs with 50 µM Crocetin and these effects were diminished from time points 60 to 120 min. (n=3). Measuring the p-Akt/Akt and p-eNOS/eNOS ratios by ELISA (D, E, and F) (n=12) by using One-way ANOVA and Tukey's Post Hoc. * p <0.05; ** p <0.01; *** p <0.001.

    Techniques Used: Reverse Transcription Polymerase Chain Reaction, Expressing, Western Blot, Incubation, Enzyme-linked Immunosorbent Assay



    Similar Products

    mouse anti human phosphor enos  (Santa Cruz Biotechnology)
    93
    Santa Cruz Biotechnology mouse anti human phosphor enos
    The molecular formula of Crocetin (A). Relative viability measured by WST-1 in HUVECs exposed to various concentrations of Crocetin over a period of 72 h (B) (n=12). Measuring HUVECs viability in the combined regime of Crocetin, Wortmannin (a PI3K inhibitor) and NMA (an <t>eNOS</t> inhibitor) (C). Data are expressed as mean ± SD (n=12). *p<0.05, **p<0.01, ***p<0.001 using one-way ANOVA with Tukey post-hoc test.
    Mouse Anti Human Phosphor Enos, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+phosphor+enos/pmc06868919-61-35-42?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 1 article reviews
    mouse anti human phosphor enos - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    The molecular formula of Crocetin (A). Relative viability measured by WST-1 in HUVECs exposed to various concentrations of Crocetin over a period of 72 h (B) (n=12). Measuring HUVECs viability in the combined regime of Crocetin, Wortmannin (a PI3K inhibitor) and NMA (an eNOS inhibitor) (C). Data are expressed as mean ± SD (n=12). *p<0.05, **p<0.01, ***p<0.001 using one-way ANOVA with Tukey post-hoc test.

    Journal: EXCLI Journal

    Article Title: Crocetin promotes angiogenesis in human endothelial cells through PI3K-Akt-eNOS signaling pathway

    doi: 10.17179/excli2019-1175

    Figure Lengend Snippet: The molecular formula of Crocetin (A). Relative viability measured by WST-1 in HUVECs exposed to various concentrations of Crocetin over a period of 72 h (B) (n=12). Measuring HUVECs viability in the combined regime of Crocetin, Wortmannin (a PI3K inhibitor) and NMA (an eNOS inhibitor) (C). Data are expressed as mean ± SD (n=12). *p<0.05, **p<0.01, ***p<0.001 using one-way ANOVA with Tukey post-hoc test.

    Article Snippet: Briefly, we transferred 100 μl rabbit anti-human VEGFR-1 (Dilution: 1 μg/ml; Cat no: ab32152; Abcam), rabbit anti-human VEGFR-2 (Dilution: 1 μg/ml; Cat no: ab39256; Abcam), mouse anti-human eNOS (Cat no: sc-376542, Santa Cruz Biotechnology) and mouse anti-human phosphor eNOS (Cat no: sc-81510, Santa Cruz Biotechnology) into each well of polystyrene treated 96-well plate (SPL) and kept them overnight at 4 °C.

    Techniques:

    Gelatin zymogram showing MMP-9 and MMP-2 activities in HUVECs treated with Crocetin (A) (n=3). RT-PCR analysis of VEGF expression (B) (n=3). Western blot analysis of p-Akt/Akt ratio (C). Western blotting revealed the non-significant increase of p-Akt/Akt ratio during the 45 min-incubation of HUVECs with 50 µM Crocetin and these effects were diminished from time points 60 to 120 min. (n=3). Measuring the p-Akt/Akt and p-eNOS/eNOS ratios by ELISA (D, E, and F) (n=12) by using One-way ANOVA and Tukey's Post Hoc. * p <0.05; ** p <0.01; *** p <0.001.

    Journal: EXCLI Journal

    Article Title: Crocetin promotes angiogenesis in human endothelial cells through PI3K-Akt-eNOS signaling pathway

    doi: 10.17179/excli2019-1175

    Figure Lengend Snippet: Gelatin zymogram showing MMP-9 and MMP-2 activities in HUVECs treated with Crocetin (A) (n=3). RT-PCR analysis of VEGF expression (B) (n=3). Western blot analysis of p-Akt/Akt ratio (C). Western blotting revealed the non-significant increase of p-Akt/Akt ratio during the 45 min-incubation of HUVECs with 50 µM Crocetin and these effects were diminished from time points 60 to 120 min. (n=3). Measuring the p-Akt/Akt and p-eNOS/eNOS ratios by ELISA (D, E, and F) (n=12) by using One-way ANOVA and Tukey's Post Hoc. * p <0.05; ** p <0.01; *** p <0.001.

    Article Snippet: Briefly, we transferred 100 μl rabbit anti-human VEGFR-1 (Dilution: 1 μg/ml; Cat no: ab32152; Abcam), rabbit anti-human VEGFR-2 (Dilution: 1 μg/ml; Cat no: ab39256; Abcam), mouse anti-human eNOS (Cat no: sc-376542, Santa Cruz Biotechnology) and mouse anti-human phosphor eNOS (Cat no: sc-81510, Santa Cruz Biotechnology) into each well of polystyrene treated 96-well plate (SPL) and kept them overnight at 4 °C.

    Techniques: Reverse Transcription Polymerase Chain Reaction, Expressing, Western Blot, Incubation, Enzyme-linked Immunosorbent Assay